FWA
CEMI

Freedom Wealth Alliance’s Chembio diagnostics, Inc. CEMI Stock Holding History

Freedom Wealth Alliance’s Portfolio CEMI Stock Details CEMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-9,831
Closed -$2.16K – 482
2022
Q4 		$2.16K Buy
+9,831
New +$2.94K ﹤0.01% 385

Other funds holding CEMI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
PenderFund Capital Management Vancouver, British Columbia, Canada $639M AUM 31.05% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return

Freedom Wealth Alliance's CEMI Position: Q1 2023 in Review

Freedom Wealth Alliance sold out of Chembio diagnostics, Inc. (CEMI) in Q1 2023, closing a stake of 9,831 shares — an estimated $2.16K sold.

Freedom Wealth Alliance first reported a position in CEMI in Q4 2022 and held it in 1 quarter. The position peaked at $2.16K in Q4 2022. 30 funds tracked by Wall St. Rank hold CEMI as of Q1 2023.

  • Freedom Wealth Alliance reported no remaining Chembio diagnostics, Inc. position as of Q1 2023 after selling out during the quarter.
  • Freedom Wealth Alliance sold 9,831 Chembio diagnostics, Inc. shares in Q1 2023, an estimated $2.16K.
  • Freedom Wealth Alliance first reported a position in Chembio diagnostics, Inc. in Q4 2022 and held it in 1 quarter.
  • Freedom Wealth Alliance's Chembio diagnostics, Inc. position peaked at $2.16K in Q4 2022.
  • 30 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q1 2023.

Based on Freedom Wealth Alliance's 13F filing for Q1 2023, filed 25 Apr 2023.